摘要
资产重组是当前一个国际性的潮流, 我国医药行业也正在积极进行结构调整, 优化组合, 提高经济效益和竞争能力。本文就我国医药行业集团化的必要性及其发展过程中应注意的几个问题进行阐述, 给人们以启示。
In order to improve the economic benefit and the competing capacity, pharmaceutical industry is adopting vigorous measures to regulate the structure and to optimize the composition of the enterprises. The necessity of the forming of group and the matters needing attention in its development are discussed in this paper.
出处
《中国药事》
CAS
1999年第5期304-306,共3页
Chinese Pharmaceutical Affairs
关键词
医药行业
资产重组
经济效益
集团化
realignment of assets
economic benefit
forming of group